The Hungarian cross-cultural adaptation of the MMQL-AF for measuring quality of life in adolescents with cancer

匈牙利对MMQL-AF量表进行跨文化改编,用于测量癌症青少年患者的生活质量

阅读:1

Abstract

With improvements in childhood cancer survival, attention has shifted toward health-related quality of life (HRQoL) and long-term treatment effects. This study aimed to validate the Hungarian version of the Minneapolis-Manchester Quality of Life Instrument - Adolescent Form (MMQL-AF) and explore factors associated with HRQoL among adolescents and young people with cancer. Ninety-two patients with cancer (46 receiving active treatment and 46 ≥ 1 year post-treatment) and 46 healthy controls completed the MMQL-AF. The MMQL-AF was translated into Hungarian in accordance with Beaton et al. and TARES (2024) guidelines. Reliability was assessed using Cronbach's alpha and intra-class correlation coefficients (ICCs). Validity was evaluated by correlations with the Hungarian Pediatric Quality of Life Inventory (PedsQL 4.0) and by comparing scores across groups. Five items were removed during confirmatory factor analysis (CFA) to improve model fit. The MMQL-AF demonstrated acceptable reliability (Cronbach's alpha 0.73-0.90; ICC 0.78-0.96; RMSEA = 0.062; 90% CI: 0.055-0.069; CFI = 0.828; TLI = 0.814; SRMR = 0.079; GFI = 0.962) and strong concurrent validity with PedsQL scores. Cancer patients reported significantly lower HRQoL than healthy peers (mean 3.58 vs. 3.81; mean difference 0.23; 95% CI: 0.05-0.41; p = 0.012). No significant difference emerged between patients on active treatment and patients off treatment. Patients with bone, soft-tissue, or central nervous system tumors reported worse outcomes (p = 0.015). Positive parental relationships were strongly associated with a better outlook (p < 0.001). The Hungarian MMQL-AF demonstrated acceptable reliability and validity for assessing HRQoL among adolescents and young people with cancer. Tumor type and family environment were associated with differences in the well-being of the patients. This instrument enables comprehensive HRQoL assessment in Hungarian pediatric oncology, supporting identification of at-risk groups and informing survivorship care strategies tailored to medical and psychosocial needs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。